Search
UK MHRA Guidance: Clinical Trials for Medicines: Apply for Authorisation in the UK & Early Access to Medicines Scheme (EAMS)
The UK regulatory environment now offers two important pathways for bringing innovative medicinal therapies to patients: The Early Access to Medicines Scheme (EAMS) , which permits earlier availability of new medicines under conditions of unmet medical need; and The MHRA’s guidance “ Clinical trials for medicines: apply for authorisation in the UK ” , which provides the regulatory framework for initiating clinical trials of investigational medicinal products. These 2 guidance
Sharan Murugan
1 day ago2 min read
UK MHRA Guidance: Apply for the Early Access to Medicines Scheme (EAMS)
The Medicines and Healthcare Products Regulatory Agency (MHRA) published guidance on "Apply for the early access to medicines scheme...
Sharan Murugan
Aug 18, 20242 min read